99 related articles for article (PubMed ID: 2177066)
1. [The EPR spectra of the ribonucleotide reductase in the tumorous tissues and organs of tumor-bearing animals].
Pulatova MK; Filatov DE; Sharygin VL; Gorbacheva LB; Gudtsova KV; Kuropteva ZV; Zhumabaeva TT; Shamaev VI; Korman DB
Izv Akad Nauk SSSR Biol; 1990; (5):737-48. PubMed ID: 2177066
[TBL] [Abstract][Full Text] [Related]
2. [Ribonucleotide reductase--a "target" of the action of nitrosomethylurea].
Filatov DE; Kudriavtsev ME; Baĭder LM; Sharygin VL; Griakalov KV; Pulatova MK; Korman DB
Izv Akad Nauk SSSR Biol; 1991; (4):528-39. PubMed ID: 1664839
[TBL] [Abstract][Full Text] [Related]
3. In vivo growth of mouse leukemia L1210 cells with metabolic alterations in the subunits of ribonucleotide reductase.
Somerville L; Cory AH; Cory JG
In Vivo; 2002; 16(3):175-7. PubMed ID: 12182112
[TBL] [Abstract][Full Text] [Related]
4. [Changes in the activity of thymidine kinase, ribonucleotide reductase and DNA-polymerases during the development of leukemia P388 in mice].
Dederer LIu; Sokolova IS; Gudtsova KV; Gorbacheva LB
Dokl Akad Nauk SSSR; 1990; 313(1):219-22. PubMed ID: 2090418
[No Abstract] [Full Text] [Related]
5. [Changes in ribonucleotide reductase activity in mouse leukemic cells and spleen during in vivo tumor growth and hydroxyurea administration].
Gudtsova KV; Pulatova MK; Gorbacheva LB
Dokl Akad Nauk SSSR; 1987; 297(2):480-2. PubMed ID: 2827980
[No Abstract] [Full Text] [Related]
6. Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice.
Novotny L; Rauko P; Liska J; Elford HL; Szekeres T
Cancer Lett; 2006 Feb; 233(1):178-84. PubMed ID: 15885888
[TBL] [Abstract][Full Text] [Related]
7. [The radical enzyme ribonucleotide reductase in animal tissues with a high proliferative activity].
Pulatova MK; Avakian MA; Sharygin VL; Postnov LA; Bibikova AD
Izv Akad Nauk SSSR Biol; 1986; (5):721-6. PubMed ID: 3023468
[No Abstract] [Full Text] [Related]
8. Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells.
Carter GL; Cory JG
Cancer Res; 1988 Oct; 48(20):5796-9. PubMed ID: 2844392
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of ribonucleotide reductase by gallium in murine leukemic L1210 cells.
Chitambar CR; Narasimhan J; Guy J; Sem DS; O'Brien WJ
Cancer Res; 1991 Nov; 51(22):6199-201. PubMed ID: 1933878
[TBL] [Abstract][Full Text] [Related]
10. [Identification of electron spin resonance signals of ribonucleotide reductase in animal tissues with high proliferative activity].
Pulatova MK; Avakian MA; Sharygin VL
Biofizika; 1986; 31(2):340-2. PubMed ID: 3008860
[TBL] [Abstract][Full Text] [Related]
11. Substituted 2-acylpyridine-alpha-(N)-hetarylhydrazones as inhibitors of ribonucleotide reductase activity and L1210 cell growth.
Cory JG; Downes DL; Cory AH; Schaper KJ; Seydel JK
Anticancer Res; 1994; 14(3A):875-9. PubMed ID: 8074487
[TBL] [Abstract][Full Text] [Related]
12. Characterization of mouse leukemia L1210 cells resistant to the ribonucleotide reductase inhibitor 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone.
Cory AH; Sato A; Thompson DP; Cory JG
Oncol Res; 1996; 8(10-11):449-56. PubMed ID: 9114437
[TBL] [Abstract][Full Text] [Related]
13. [A morphofunctional evaluation of the immunomodulating action of nitrosomethylurea].
Potapov IuN; Khaleev DV; Krutova TV
Eksp Klin Farmakol; 1995; 58(3):48-50. PubMed ID: 7663298
[TBL] [Abstract][Full Text] [Related]
14. Effects of combinations of drugs having different modes of action at the ribonucleotide reductase site on growth of L1210 cells in culture.
Sato A; Carter GL; Bacon PE; Cory JG
Cancer Res; 1982 Nov; 42(11):4353-7. PubMed ID: 6751522
[TBL] [Abstract][Full Text] [Related]
15. [The dose dependence of the development of compensatory-restorative body reactions to irradiation. The EPR method].
Pulatova MK; Filatov DE; Shliakova TG; Sharygin VL; Beletskiĭ VP; Chernov GA
Izv Akad Nauk SSSR Biol; 1992; (2):215-33. PubMed ID: 1331216
[TBL] [Abstract][Full Text] [Related]
16. [Mechanisms of the antitumor action of spirobromine in mice with leukemia P-388].
Sokolova IS; Riabokon' NA; Chernov VA; Gorbacheva LB
Izv Akad Nauk SSSR Biol; 1989; (5):660-5. PubMed ID: 2584530
[TBL] [Abstract][Full Text] [Related]
17. [Time- and dose-dependent post-irradiation changes of Fe3+-transferrin and Cu2+-ceruloplasmin pools in blood, their influence on ribonucleotide reductase activity in animal tissues and the effects of radioprotectors].
Sharygin VL; Pulatova MK; Shliakova TG; Todorov IN
Radiats Biol Radioecol; 2003; 43(6):662-77. PubMed ID: 14963934
[TBL] [Abstract][Full Text] [Related]
18. [Studies on the possible causes of decreasing NK cell activity in tumor-bearing mice. I. The number of NK cells in the spleens of tumor-bearing mice is higher than that in normal mice].
Fu JY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Dec; 11(6):421-4. PubMed ID: 2534577
[TBL] [Abstract][Full Text] [Related]
19. [Biochemical mechanisms of resistance to a new antineoplastic agent amin(cyclopeptidylamin)-S-(-)-malatoplatinum (II) (cycloplatam)].
Dederer LIu; Lankin VZ; Konovalova AL; Gorbacheva LB
Biokhimiia; 1995 Apr; 60(4):602-9. PubMed ID: 7779982
[TBL] [Abstract][Full Text] [Related]
20. EPR study of the mixed-valent diiron sites in mouse and herpes simplex virus ribonucleotide reductases. Effect of the tyrosyl radical on structure and reactivity of the diferric center.
Davydov RM; Davydov A; Ingemarson R; Thelander L; Ehrenberg A; Gräslund A
Biochemistry; 1997 Jul; 36(30):9093-100. PubMed ID: 9230041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
